These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2083519)

  • 21. Plant-based formulation for bronchial asthma: a controlled clinical trial to compare its efficacy with oral salbutamol and theophylline.
    Murali PM; Rajasekaran S; Krishnarajasekar OR; Perumal T; Nalini K; Lakshmisubramanian S; Deivanayagam CN
    Respiration; 2006; 73(4):457-63. PubMed ID: 16308544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of childhood asthma--addition of oral controlled release salbutamol to an inhaled treatment regimen.
    Cammell JS; Holdaway MD; Smith NA
    N Z Med J; 1991 Apr; 104(910):164-5. PubMed ID: 2020463
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetic characteristics of a novel controlled-release sprinkle formulation of salbutamol.
    Mulligan S; Devane J; Martin M
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():312-4. PubMed ID: 1820899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo effect of salbutamol on histamine release from human basophils.
    Chazan R; Walajtys-Rode E; Grubek-Jaworska H; Madalinska M; Droszcz W
    Int J Clin Pharmacol Ther Toxicol; 1991 Jan; 29(1):9-13. PubMed ID: 1706328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the efficacy and systemic effects of 4 mg and 8 mg formulations of salbutamol controlled release in patients with asthma.
    Lipworth BJ; Clark RA; Dhillon DP; Palmer JB; McDevitt DG
    Eur J Clin Pharmacol; 1990; 39(3):281-5. PubMed ID: 2257867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the metabolic effects of salbutamol administered in a one-minute bolus and a continuous infusion in patients with bronchial asthma.
    Elegbeleye OO; Williams KO; Femi-Pearse D
    Isr J Med Sci; 1978 Apr; 14(4):455-8. PubMed ID: 669922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled release salbutamol tablets versus sustained release theophylline tablets in the control of reversible obstructive airways disease.
    Vyse T; Cochrane GM
    J Int Med Res; 1989; 17(1):93-8. PubMed ID: 2651178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of a controlled-release aminophylline tablet (Phyllocontin Continus) as a concomitant therapy in patients receiving salbutamol.
    Boyd G; Clark CJ
    J Int Med Res; 1979; 7 Suppl 1():34-5. PubMed ID: 374162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and preparation of controlled release pellets of salbutamol by the air suspension technique.
    Govender T; Dangor CM
    J Microencapsul; 1997; 14(4):445-55. PubMed ID: 9229344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of procaterol and salbutamol in patients with bronchial asthma].
    Płusa T; Zaraś E; Kruszewski J
    Pneumonol Alergol Pol; 1992; 60(11-12):48-52. PubMed ID: 1303778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled release salbutamol tablets versus aminophylline in the control of reversible airways obstruction.
    Higenbottam TW; Khan MA; Williams DO; Mikhail JR; Peake MD; Hughes J
    J Int Med Res; 1989; 17(5):435-41. PubMed ID: 2680678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of controlled release salbutamol on nocturnal cough in asthma.
    Hoskyns EW; Thomson A; Decker E; Hutchins A; Simpson H
    Arch Dis Child; 1991 Oct; 66(10):1209-12. PubMed ID: 1953004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical experience with delayed-action salbutamol].
    Zanotelli F
    Minerva Med; 1976 Mar; 67(16):1019-22. PubMed ID: 1264374
    [No Abstract]   [Full Text] [Related]  

  • 34. [Our experience with salbutamol in the treatment of bronchial asthma and chronic asthmatiform bronchitis].
    Serembe M
    Minerva Med; 1976 Mar; 67(16):1023-4. PubMed ID: 1264375
    [No Abstract]   [Full Text] [Related]  

  • 35. Single dose and steady-state pharmacokinetics of 4 mg and 8 mg oral salbutamol controlled-release in patients with bronchial asthma.
    Lipworth BJ; Clark RA; Dhillon DP; Charter MK; Palmer JB; McDevitt DG
    Eur J Clin Pharmacol; 1989; 37(1):49-52. PubMed ID: 2687008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in static and dynamic volumes in bronchial asthmatics treated with salbutamol by oral administration].
    Carnimeo N; Maiorano V; Iaia E
    Minerva Med; 1976 Apr; 67(17):1147-50. PubMed ID: 1264392
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of tolerance after continuous and prolonged oral administration of salbutamol to asthmatic patients.
    Bhatia SP; Davies HJ
    Br J Clin Pharmacol; 1975 Oct; 2(5):463-6. PubMed ID: 1233072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of a controlled-release tablet of salbutamol given twice daily with a standard tablet given four times daily in the management of chronic obstructive lung disease.
    Maesen FP; Smeets JJ
    Eur J Clin Pharmacol; 1986; 31(4):431-6. PubMed ID: 3816923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of salbutamol in bronchial asthma and in chronic obstructive bronchopathy].
    Guideri A
    Minerva Med; 1976 Apr; 67(17):1115-9. PubMed ID: 1264387
    [No Abstract]   [Full Text] [Related]  

  • 40. [Data on the use in pediatrics of oral administration of salbutamol in soluble tablets in the therapy of asthmatic attacks].
    Miraglia del Giudice M; Capristo A; Tomasi L
    Pediatria (Napoli); 1975 Jun; 83(2):220-31. PubMed ID: 1178242
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.